Sunesis Advisors’s AbbVie ABBV Stock Holding History

Sunesis Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.4M	Buy	+9,159	New	+$2.35M	1.24%	10

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return

B. Metzler seel. Sohn & Co Frankfurt, Germany $11.5B AUM 29.17% 1-Year Est. Return

Sunesis Advisors's ABBV Position: Q3 2026 in Review

Sunesis Advisors opened a new position in AbbVie (ABBV) in Q3 2026: 9,159 shares worth $2.4M. The stake represents 1.24% of the portfolio and ranks #10 among its holdings.

1,999 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

Sunesis Advisors held 9,159 shares of AbbVie worth $2.4M as of Q3 2026.
AbbVie was a new Sunesis Advisors position in Q3 2026.
AbbVie made up 1.24% of Sunesis Advisors's portfolio in Q3 2026, its #10 holding.
1,999 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Sunesis Advisors's 13F filing for Q3 2026, filed 26 Oct 2026.